EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Diagnostic performance of the FluoroType MTBDR assay for rifampicin and isoniazid resistance in routine laboratory setting

Ivy Rukasha, Kabelo G Kaapu, Molebogeng R Lekalakala-Mokaba

African Journal of Primary Health Care & Family Medicine · 08.01.2026 · 19 (1)

DOI: 10.4102/phcfm.v18i1.5034 ↗

Kurz gefasst

Fachartikel in der Zeitschrift African Journal of Primary Health Care & Family Medicine, online erschienen am 08.01.2026. Verfasst von Ivy Rukasha und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, School of Medicine, Faculty of Health Sciences, University of Limpopo, Polokwane, South Africa; and Department of Microbiolo…. Hauptthemen laut MEDLINE: Isoniazid, Rifampin, Mycobacterium tuberculosis, Tuberculosis, Multidrug-Resistant. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Drug-resistant tuberculosis (DR-TB) continues to be a major public health threat, especially in high-burden settings like South Africa. Rapid and accurate diagnosis of resistance to rifampicin (RIF) and isoniazid (INH) is essential to ensure that patients receive the right treatment as early as possible. Current diagnostic tools, though effective, have limitations. This study addresses the urgent need for faster, reliable alternatives to improve DR-TB detection.

Aim

The aim of this study is to assess the performance of the FluoroType MTBDR assay in detecting resistance to RIF and INH in a real-world diagnostic setting.

Setting

The study was carried out at the National Health Laboratory Services (NHLS) Polokwane Laboratory, a routine laboratory in Limpopo province, South Africa.

Methods

We tested 152 Mycobacterium tuberculosis (MTB) isolates collected from the 2023 laboratory repository using the FluoroType MTBDR version 2 assay. These results were compared with those from two established methods: GenoType MTBDRplus and Xpert MTB/RIF Ultra. Whole genome sequencing (WGS) was used to resolve any discrepancies, serving as the reference standard. Diagnostic accuracy was evaluated using sensitivity, specificity and predictive values.

Results

Of the 152 isolates, 65% were drug-resistant. FluoroType MTBDR showed excellent performance – 100% specificity and 96% sensitivity for RIF resistance and 91% sensitivity and 99% specificity for INH resistance – competing with the GenoType MTBDRplus.

Conclusion

FluoroType MTBDR offers a reliable, rapid alternative for detecting DR-TB, with the potential to improve timely diagnosis and treatment. Contribution: This study highlights the FluoroType MTBDR assay as a valuable diagnostic tool for routine use, contributing to improved TB control strategies, especially in resource-limited, high-burden settings, consistent with the journal’s scope.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

IsoniazidRifampinMycobacterium tuberculosisTuberculosis, Multidrug-ResistantAntitubercular AgentsHumansSouth AfricaSensitivity and SpecificityMicrobial Sensitivity Tests

Stichwörter der Autor:innen

drug resistanceisoniazidmolecular methodsmultidrug resistancerifampicintuberculosis

Substanzen

IsoniazidRifampinAntitubercular Agents

Autor:innen und Institutionen

  • Department of Pathology, School of Medicine, Faculty of Health Sciences, University of Limpopo, Polokwane, South Africa; and Department of Microbiology, National Health Laboratory Service, Polokwane. ivy.rukasha@ul.ac.z…

Zitieren

APA

Rukasha, I., Kaapu, K. G., & Lekalakala-Mokaba, M. R. (2026). Diagnostic performance of the FluoroType MTBDR assay for rifampicin and isoniazid resistance in routine laboratory setting. African Journal of Primary Health Care & Family Medicine, 19(1). https://doi.org/10.4102/phcfm.v18i1.5034

Vancouver

Rukasha I, Kaapu KG, Lekalakala-Mokaba MR. Diagnostic performance of the FluoroType MTBDR assay for rifampicin and isoniazid resistance in routine laboratory setting. African Journal of Primary Health Care & Family Medicine. 2026;19(1). doi:10.4102/phcfm.v18i1.5034

BibTeX
@article{Rukasha2026,
  author = {Rukasha, Ivy and Kaapu, Kabelo G and Lekalakala-Mokaba, Molebogeng R},
  title = {Diagnostic performance of the FluoroType MTBDR assay for rifampicin and isoniazid resistance in routine laboratory setting},
  journal = {African Journal of Primary Health Care & Family Medicine},
  year = {2026},
  volume = {19},
  number = {1},
  doi = {10.4102/phcfm.v18i1.5034}
}
Kostenlos starten →